Plautz GE - Search Results

1

Systemic T cell adoptive immunotherapy of malignant gliomas.

Plautz GE, Barnett GH, Miller DW, Cohen BH, Prayson RA, Krauss JC, Luciano M, Kangisser DB, Shu S. Plautz GE, et al. J Neurosurg. 1998 Jul;89(1):42-51. doi: 10.3171/jns.1998.89.1.0042. J Neurosurg. 1998. PMID: 9647171 Clinical Trial.

2

Considerations on clinical use of T cell immunotherapy for cancer.

Plautz GE, Cohen PA, Shu S. Plautz GE, et al. Arch Immunol Ther Exp (Warsz). 2003;51(4):245-57. Arch Immunol Ther Exp (Warsz). 2003. PMID: 12956434 Review.

3

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.

Kjaergaard J, Wang LX, Kuriyama H, Shu S, Plautz GE. Kjaergaard J, et al. Among authors: plautz ge. J Neurosurg. 2005 Jul;103(1):156-64. doi: 10.3171/jns.2005.103.1.0156. J Neurosurg. 2005. PMID: 16121986

4

Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.

Wang LX, Shu S, Plautz GE. Wang LX, et al. Among authors: plautz ge. Cancer Res. 2005 Oct 15;65(20):9547-54. doi: 10.1158/0008-5472.CAN-05-1175. Cancer Res. 2005. PMID: 16230420

5

Defining the synergistic effects of irradiation and T-cell immunotherapy for murine intracranial tumors.

Plautz GE, Inoue M, Shu S. Plautz GE, et al. Cell Immunol. 1996 Aug 1;171(2):277-84. doi: 10.1006/cimm.1996.0204. Cell Immunol. 1996. PMID: 8806798

6

Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.

Kagamu H, Touhalisky JE, Plautz GE, Krauss JC, Shu S. Kagamu H, et al. Among authors: plautz ge. Cancer Res. 1996 Oct 1;56(19):4338-42. Cancer Res. 1996. PMID: 8813119

7

Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.

Inoue M, Plautz GE, Shu S. Inoue M, et al. Among authors: plautz ge. Cancer Res. 1996 Oct 15;56(20):4702-8. Cancer Res. 1996. PMID: 8840987

8

Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.

Plautz GE, Touhalisky JE, Shu S. Plautz GE, et al. Cell Immunol. 1997 Jun 15;178(2):101-7. doi: 10.1006/cimm.1997.1140. Cell Immunol. 1997. PMID: 9225000

9

Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules.

Liu J, Finke J, Krauss JC, Shu S, Plautz GE. Liu J, et al. Among authors: plautz ge. Cancer Immunol Immunother. 1998 Jul;46(5):268-76. doi: 10.1007/s002620050487. Cancer Immunol Immunother. 1998. PMID: 9690455 Free PMC article.

10

T cell adoptive immunotherapy of newly diagnosed gliomas.

Plautz GE, Miller DW, Barnett GH, Stevens GH, Maffett S, Kim J, Cohen PA, Shu S. Plautz GE, et al. Clin Cancer Res. 2000 Jun;6(6):2209-18. Clin Cancer Res. 2000. PMID: 10873070 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters